About 300 reports

The offers a wide range of devices and kits for autoimmune diseases worldwide.

  • Endoscope
  • Mental Health
  • World
  • Forecast
  • Smith & Nephew Plc
  • IDENTIFYING FACTORS IMPACTING MARKET GROWTH
  • MARKET OVERVIEW

The functioning of the brain and nervous system is severely affected by various autoimmune diseases and neurological disorders such as Alzheimer' s disease, dementia, MS, encephalitis, genetic brain disorders, brain tumors, Parkinson' s disease, a

  • Mental Health
  • Forecast
  • Compumedics Limited
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • 8.3 Disease List
  • NEURODEGENERATIVE DISORDERS THERAPEUTICS MARKET, COMORBIDITIES ASSOCIATED WITH

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha ## beta ## integrin.

  • Mental Health
  • World
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • 2.1.4 Causes of Myasthenia Gravis
  • 2.1 Overview of Myasthenia Gravis

Myasthenia gravis is an autoimmune disease because the immune system-which normally protects the body from foreign organisms-mistakenly attacks itself.

  • Mental Health
  • United States
  • World
  • Market Size
  • Pfizer Inc.

These factors are infections, inflammation, stroke, toxins, trauma, metabolic disorders, autoimmune diseases, genetic diseases, and reactions to certain medications.

  • Mental Health
  • Allergan plc
  • Eisai Co., Ltd.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • BRISTOL-MYERS SQUIBB

In March 2016, Bristol-Myers Squibb announced the acquisition of Padlock, a biotechnology company focused on the development of autoimmune diseases medicines.

  • Mental Health
  • Forecast
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • FACTORS AFFECTING THE ADOPTION RATES OF MYASTHENIA GRAVIS DRUGS MARKET
  • Mediu

Myasthenia gravis is an autoimmune neuromuscular disease characterized by weakness of the skeletal muscles of the body.

  • Mental Health
  • Alexion Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Flamel Technologies S.A.
  • Pfizer Inc.

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Mental Health
  • East Asia
  • Japan
  • Forecast

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Mental Health
  • Brazil
  • South America
  • Forecast

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Mental Health
  • Latin America
  • Mexico
  • North America

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Mental Health
  • Australasia
  • Australia
  • Oceania

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Mental Health
  • China
  • East Asia
  • Forecast
  • 7.1 GROWTH DRIVERS

The ESRD is caused due to diabetic nephropathy, high blood pressure, autoimmune diseases, infection, drugs, traumatic injury and nephrotoxic poisons.

  • Mental Health
  • World
  • Market Size
  • ConvaTec Inc.
  • Hollister Incorporated

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Mental Health
  • India
  • South Asia
  • Forecast

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Mental Health
  • Italy
  • Southern Europe
  • Forecast

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Mental Health
  • Eastern Europe
  • Russia
  • Forecast

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Mental Health
  • East Asia
  • South Korea
  • Forecast

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Endoscope
  • Mental Health
  • Southern Europe
  • Spain
  • Forecast
  • 2.2 Disease-Modifying Therapy (DMT) Patient Numbers & Forecast

Multiple sclerosis market is one of the most common neurological disorder diseases in the world.

  • Mental Health
  • Neurological Disorder
  • United States
  • World
  • Forecast

IN ADDITION, IT IS BEING INVESTIGATED AS A POSSIBLE TREATMENT FOR OTHER AUTOIMMUNE DISEASES AS WELL.

  • Mental Health
  • Neurological Disorder
  • World
  • Forecast
  • Antares Pharma, Inc.
  • 3.3 GLOBAL AND HISTORICAL TRENDS
  • 4.1 BIBLIOGRAPHY

Narcolepsy: Epidemiology Forecast to 2027 Summary Narcolepsy is a chronic disorder that is mainly characterized by excessive daytime sleepiness and, in the majority of individuals, cataplexy-a sudden loss of muscle tone during wakefulness that is evoked by strong, usually positive, emotions.The onset...

  • Epidemiology
  • Mental Health
  • Pathology
  • United States
  • Forecast
  • Identifying factors impacting market growth
  • EMEA - Market size and forecast 2017-2022

Some of the most common ear disorders affecting a large group of population (children and aged people) include otitis media, external ear infections, cerumen, and autoimmune ear disease.

  • Endoscope
  • Endoscopic Device
  • World
  • Forecast
  • 2.2 Disease-Modifying Therapy (DMT) Patient Numbers & Forecast

Europe Multiple Sclerosis Patient Numbers (2011 - Multiple sclerosis (MS) is one of the world' s most common neurological disorders.

  • Mental Health
  • Neurological Disorder
  • Europe
  • World
  • Forecast

Its product pipeline focuses on treating cardiovascular and metabolic diseases, cancer, respiratory, inflammation and autoimmune diseases, infection, neurological disorders and gastrointestinal diseases.

  • Hospital
  • Mental Health
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.

In this condition individuals experience one or more depressive episodes followed by at least one episode of hypomania.

  • Mental Health
  • Allergan plc
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • 2 Multiple Sclerosis Executive Summary

Smoking Cod-liver oil usage Obesity Comorbidities Prevalence (%) in MS Psychiatric disease ##. ##% ##. ##% ##. ##% Autoimmune disease Cardiovascular disease Cancer ##. ##% Metabolic disease ##. ##% MS is a chronic immune-mediated disease of the central nervous syste

  • Mental Health
  • Italy
  • Japan
  • United States
  • Forecast
  • Market trends

For instance, Prednisone is approved for the treatment of inflammatory diseases and autoimmune disease, but this medication is also used for the treatment of infantile spasms market.

  • Mental Health
  • Anavex Life Sciences Corp.
  • GW Pharmaceuticals plc
  • Insys Therapeutics, Inc.
  • Lundbeck Inc.

It is considered to be an autoimmune disease, which happens when an individual' s immune system attacks healthy cells in the body.

  • Mental Health
  • Asterias Biotherapeutics, Inc.
  • Athersys, Inc.
  • Celgene Corporation
  • Enlivex
  • 3.3.1 DRIVERS AND OPPORTUNTIES

According to one estimate, the Parkinson' s disease affects over ##% population in age group of ## and above and reaches ##% in age group of ##.

  • Mental Health
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.

Scale = ##-##, where ## is low impact, and ## is high impact.

  • Mental Health
  • World
  • Market Size
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.